Pfizer Inc
President Joe Biden likely has BA.5 variant but Covid-19 symptoms ‘continue to improve,’ doctor says
President Joe Biden, who tested positive today for Covid-19 this morning, posts on Twitter “Folks, I’m doing great. Thanks for your concern. Just called Senator Casey, Congressman Cartwright, and Mayor Cognetti (and my Scranton cousins!) to send my regrets for missing our event today.” Courtesy: White House President Joe Biden likely has the BA.5 Covid-19 variant […]
Read More
Republican AG group holds private retreat for corporate donors at swanky Palm Beach resort
Anti-abortion activists demonstrate outside the Supreme Court of the United States in Washington, June 13, 2022. Evelyn Hockstein | Reuters The Republican Attorneys General Association is hosting a private retreat for its corporate donors at a luxury resort in Florida this weekend — on the heels of the GOP’s long-sought win in getting Roe v. […]
Read More
FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration has authorized Novavax’s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. […]
Read More
Cramer’s lightning round: Gentex is a buy
Chegg Inc: “I don’t know what to make of Chegg. … To me, it seems like the bulls are going to win on this stock.” Moderna Inc: “I think that stock has now come down enough. I would want to own Moderna. I do like Pfizer more.” ONEOK Inc: “Keep it. … I think that’s […]
Read More
‘Dividend aristocrats’: Strategists name high-yielding stocks to ride out a bear market
U.S. stocks fell into bear market territory last month — and the wild swings since have made it hard to predict where the market is going next. The S & P 500 logged its worst performance in 50 years during the first half of this year, as it tumbled nearly 20%, and the Nasdaq is […]
Read More
Three stock market themes to play in the third quarter
The health care sector is often a sleepy performer but in this market turmoil it may prove to be one of the areas of not only safety in the third quarter — but growth. The third quarter could be a turbulent time, after the worst first half for stocks since 1970. As investors fear rampant […]
Read More
Investment banks trumpet fresh ideas in new second-half stock trades
Major investment banks expect the stock market’s volatility to continue in the second half of 2022. A brutal market sell-off saw the S & P 500 suffer its worst first half since 1970 as the Nasdaq Composite plummeted deep into a bear market. Meanwhile, the Federal Reserve kickstarted an aggressive rate hiking cycle to curb […]
Read More
Stocks making the biggest moves midday: RH, Carnival, Universal Health Services and more
Interior Design area of the Restoration Hardware store in the Meatpacking District of New York. Source: RH Check out the companies making headlines in midday trading Thursday. RH — Shares of RH fell 10.6% after the high-end furniture chain slashed its full-year outlook and said consumer demand for its products could continue to soften in […]
Read More
Stocks making the biggest moves premarket: Walgreens, Constellation Brands, RH and others
Check out the companies making headlines before the bell: Walgreens (WBA) – The drug store operator earned an adjusted 96 cents per share for its latest quarter, 4 cents above estimates, with revenue also beating analyst forecasts. Walgreens also reaffirmed its full-year guidance, forecasting low-single-digit adjusted earnings growth. The stock fell 2.7% in premarket action. […]
Read More
FDA panel recommends changing Covid shots to fight omicron this fall
A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, January 29, 2021. Mike Segar | Reuters The Food and Drug Administration’s panel of independent vaccine experts on Tuesday voted 19 to 2 to […]
Read More